Resumen
Spontaneous intracerebral hemorrhage (ICH) results in high rates of morbidity and mortality, with intraventricular hemorrhage (IVH) being associated with even worse outcomes. Therapeutic interventions in acute ICH have continued to emerge with focus on arresting hemorrhage expansion, clot volume reduction of both intraventricular and parenchymal hematomas, and targeting perihematomal edema and inflammation. Large randomized controlled trials addressing the effectiveness of rapid blood pressure lowering, hemostatic therapy with platelet transfusion, and other clotting complexes and hematoma volume reduction using minimally invasive techniques have impacted clinical guidelines. We review the recent evolution in the management of acute spontaneous ICH, discussing which interventions have been shown to be safe and which may potentially improve outcomes.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 1757-1767 |
| Número de páginas | 11 |
| Publicación | Neurotherapeutics |
| Volumen | 17 |
| N.º | 4 |
| DOI | |
| Estado | Published - oct 2020 |
Nota bibliográfica
Publisher Copyright:© 2020, The American Society for Experimental NeuroTherapeutics, Inc.
Financiación
Dr. Hanley reports grants from NIH and personal fees from BrainScope, Neurotrope, Op2Lysis, Portola Pharmaceuticals, and medico-legal, outside the submitted work. Dr. Ziai has received grant support from NIH and compensation as a consultant for CR Bard Inc. and Portola Pharmaceuticals. Dr. Al-Kawaz reports no disclosures.
| Financiadores |
|---|
| CR Bard Inc. |
| National Institutes of Health (NIH) |
| Portola Pharmaceuticals Inc. |
ASJC Scopus subject areas
- Pharmacology
- Clinical Neurology
- Pharmacology (medical)
Huella
Profundice en los temas de investigación de 'Advances in Therapeutic Approaches for Spontaneous Intracerebral Hemorrhage'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver